Selected News from Today's FirstWord
Patent for Bristol-Myers Squibb’s Plavix set to expire Thursday
Bristol-Myers Squibb's Plavix (clopidogrel) is set to lose patent protection in the US on Thursday. The drugmaker, which sells Plavix under a partnership with Sanofi, has said it does not plan to actively market the drug in the country once it is no longer under patent. Full story
- Pfizer's Torisel fails in late-stage renal cancer study versus Bayer, Onyx's Nexavar - (Ref. FinanzNachrichten; MarketWatch; NASDAQ)
- NICE reverses earlier decision, backs Johnson & Johnson's prostate cancer drug Zytiga - (Ref. Daily Mail; The Guardian; The Telegraph; The Scotsman; London South East; BBC News; NICE; NASDAQ)
- Piramal looks to boost R&D with $635-million deal for healthcare data provider Decision Resources - (Ref. Bloomberg; Mass High Tech; India Infoline; The Wall Street Journal; Fidelity; Morningstar; MarketWatch)
Also in the News
- Products:
- AT13387,
- Botox,
- elotuzumab,
- erlotinib,
- Lu AA21004,
- sorafenib,
- Vancomycin
- Companies:
- Accentia,
- Aeterna Zentaris,
- Boehringer Ingelheim,
- Cytomedix,
- Fibrocell,
- Lilly,
- Novartis
- Markets:
- United Kingdom,
- United States
FirstWord Dossier Reports
www.fwreports.com
**NEW** The complete list of FirstWord Dossier reports can be found at www.fwreports.com
FirstWord Dossier reports provide insight, analysis and the latest thinking on important trends and the most challenging issues affecting the pharmaceutical industry today. Highly-focused, relevant, up-to-date and actionable intelligence ... reports that deliver information vital for competitive advantage.Click here to see our recent reports.
Most Read Stories in the Past Week
Recent Reports
- Building Strong Market Access Teams
- Biosimilars Regulatory Update: an evolving landscape
- Pharma Social Media Campaigns: current thinking and future outlook
- Pharma Market Insights: Closed Loop Marketing
- Pharma Sales Force Innovations: technology, training and rewards
- Pharma YouTube Channels: Content and Comment (Nexus Report)
- The Medical Device Outlook in Emerging Markets - (FirstShelf)
- The Hepatitis Market Outlook to 2015 - (FirstShelf)
- Digital Doctors: Marketing to Online Networks
- Generic Substitution: Taking a Narrow View?
- Closing the Loop: Beyond Digital Detailing
- Pharma Marketing in Latin America
- Biosimilars: Surveying the Market Landscape